相关实验视频
Updated: Jan 16, 2026

09:43
Synthesis of Immunotargeted Magneto-plasmonic Nanoclusters
Published on: August 22, 2014
15.7K
向性碳点以增强黑色素瘤免疫疗法
Ranran Zhao1, Hongxin Liu1, Zhigang Xie2
1College of Chemistry and Life Sciences, Advanced Institute of Materials Science, Changchun University of Technology, Changchun, Jilin 130012, PR China.
Journal of colloid and interface science
|September 28, 2025
概括
用乳酸修饰的基拉尔碳点增强了纳米疫苗的疗效. D-enantiomer纳米疫苗显示出优越的抗原吸收和抗瘤免疫力,突出显示了其性.
科学领域:
- 生物技术是生物技术.
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 纳米疫苗有可能提供抗原输送和瘤特异性免疫反应.
- 优化纳米疫苗的有效性和安全性仍然是一个关键的研究挑战.
研究的目的:
- 调查性和乳酸修饰对纳米疫苗性能的影响.
- 为增强抗瘤免疫力开发新型纳米疫苗.
主要方法:
- 用乳酸 (LA) 修饰成LLA/DLA的性碳点 (L/D-CD) 的制造.
- 通过将L/D-CDs和LLA/DLA与卵胺 (OVA) 结合起来,制备纳米疫苗.
- 在体外和体内对抗原吸收,免疫细胞激活和抗瘤效应的评估.
主要成果:
- 与L-enantiomers相比,D-enantiomer纳米疫苗 (D-OVA,DLAO) 显示增强了树突细胞吸收和免疫活性.
- 乳酸修饰改善了抗原处理,呈现和共刺激分子表达 (CD80,CD86).
- 在携带瘤的小鼠中,DLAO纳米疫苗诱导了显著的抗原特异性T细胞增殖和强大的治疗效果.
结论:
- 性在增强纳米疫苗抗原呈现和免疫性方面发挥着至关重要的作用.
- 乳酸修饰通过改善向和免疫细胞激活来提高纳米疫苗的有效性.
- 这些发现凸显了合性,向性纳米疫苗在增强抗瘤免疫力的潜力.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K

